Neogen Corporation Class Action Lawsuit Overview
In a significant move for investors, a law firm has announced that individuals who owned shares of Neogen Corporation during a specific time frame could seek to lead a class action lawsuit. This opportunity is particularly crucial for those who sustained substantial financial losses as a result of their investment.
Key Details About the Class Action
The class action pertains to Neogen Corporation, designated under the ticker symbol NEOG. Investors who purchased common stock of Neogen between January 5, 2023, and June 3, 2025, may have until September 16, 2025, to express their interest in becoming lead plaintiffs in this legal matter. The case is formally titled Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation, and it raises serious allegations against both the company and its executives.
The Allegations Against Neogen
The lawsuit claims that during the class period, Neogen and several of its top executives provided misleading information and failed to disclose crucial facts about its integration with the Food Safety Division of the 3M Company, which began in late 2021. This integration, initially thought to be progressing seamlessly, turned out to be fraught with issues, ultimately affecting Neogen’s market position.
Financial Concerns
On January 10, 2025, Neogen disclosed that its financial results were significantly impacted, revealing a staggering non-cash goodwill impairment charge related to the 3M acquisition. This charge, amounting to $461 million, overshadowed other financial indices, leading to a decrease in the company's stock price.
Integration Problems
Continuing into April 2025, the company published its third-quarter financial results, confirming ongoing challenges with the integration process. The fallout from these struggles resulted in increased operational costs, revenue declines, and an overall dim outlook for the company’s fiscal predictions for 2025. Such disclosures have caused significant shifts in the perception and valuation of Neogen's stock.
Importance of Lead Plaintiff Role
This class action presents an important avenue for investors to potentially recoup losses. The process of becoming a lead plaintiff is governed by the Private Securities Litigation Reform Act of 1995, which allows any investor who purchased shares during the applicable time frame to apply. Being a lead plaintiff involves representing all shareholders involved in the lawsuit and choosing a law firm to advocate on their behalf.
Robbins Geller’s Role
The legal proceedings are spearheaded by leading attorneys from Robbins Geller Rudman & Dowd LLP, a prominent firm recognized for its expertise in securities law and shareholder litigation. Their track record suggests they possess the necessary experience to navigate complex cases, ensuring that the rights of investors are effectively represented.
Company Background
Neogen Corporation is committed to providing products and services focused on food and animal safety. The company continually strives toward innovation and improvement in its offerings, with a strong emphasis on integrating advanced technologies in its operations.
Contact Information
Investors seeking further details on the lawsuit or wishing to participate as lead plaintiffs are encouraged to reach out directly. Interested parties can contact attorneys at Robbins Geller by calling 800-449-4900, or they can send an email to info@rgrdlaw.com.
Frequently Asked Questions
1. What should I do if I owned shares of Neogen Corporation?
If you owned shares during the specified class period and experienced losses, you should consider seeking legal counsel to explore your options regarding this class action lawsuit.
2. How can I become a lead plaintiff?
You can apply to be a lead plaintiff by providing necessary information to the law firm representing the class action, typically including proof of your share ownership during the class period.
3. What are the potential outcomes of this lawsuit?
The outcomes could vary from financial settlements to reformation of the company's practices, depending on the court's findings and the nature of any alleged wrongdoing.
4. Are there fees associated with participating in the lawsuit?
Typically, there are no upfront fees to participate as lead plaintiff; legal fees usually come from any recoveries made by the class.
5. Why is it important to engage in this lawsuit?
This lawsuit is crucial for holding companies accountable for their actions and safeguarding investor interests. Participation can contribute significantly to restitution efforts for affected shareholders.
